Zevra Therapeutics paid its 2 named executives $5.4M in total in FY2025 (Dec).
Pay$100 in the stock at the end of FY22 → $182
Pay of each named executive
Neil F. McFarlanePresident, Chief Executive Officer and Director
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
2 years
R. LaDuane Clifton, MBA, CPAFormer Chief Financial Officer and Treasurer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Rahsaan W. ThompsonChief Legal Officer, Secretary and Compliance Officer
| FY2025 (Dec) |
1 year
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.